RecruitingNCT04005976

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

Sponsor

The University of Texas Health Science Center, Houston

Enrollment

5,000 participants

Start Date

Jun 15, 2016

Study Type

OBSERVATIONAL

Conditions

Aortic Aneurysm Aortic Dissection Aortic Diseases

Summary

The Montalcino Aortic Consortium (MAC) will provide the infrastructure to assemble large cohorts of patients with mutations in known heritable thoracic aortic disease (H-TAD) genes, define the phenotype associated with these genes, and determine genetic and environmental modifiers of H-TAD.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with aortic aneurysm, aortic diseases, and other related conditions. The study is currently recruiting participants at 20 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(20)

HOAG memorial hospital presbyterian

Newport Beach, California, United States

Hoag Memorial Hospital Presbyterian

Newport Beach, California, United States

Sutter Health

Sacramento, California, United States

University of Kentucky

Lexington, Kentucky, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

University of Michigan

Ann Arbor, Michigan, United States

Washington University in St. Louis

St Louis, Missouri, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

St. Francis Hospital (Catholic Health)

Roslyn, New York, United States

Oregon Health & Science University

Portland, Oregon, United States

Baylor College of Medicine

Houston, Texas, United States

Texas Children's Hospital

Houston, Texas, United States

The University of Texas Health Science Center at Houston

Houston, Texas, United States

Inova Health System

Falls Church, Virginia, United States

University of Sydney

Sydney, New South Wales, Australia

Ghent University Hospital (UZ Gent)

Ghent, East Flanders, Belgium

Foothills Medical Centre / Alberta Health Services

Calgary, Alberta, Canada

Toronto General Hospital (UHN)

Toronto, Ontario, Canada

Hospital Universitari Vall d'Hebron

Barcelona, Catalonia, Spain

Great Ormond Street Hospital

London, England, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04005976

Related Trials

PregnAncy-Related Aortic DISsEction in China

NCT076722104 locations

Prospective Evaluation of Physician Modified Endografts for Aortic Disease

NCT076119681 location

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

NCT0682799018 locations

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

NCT0707838322 locations

Construction of a Prospective Cohort Database for the Perioperative Period of Cardiac Surgery

NCT076623171 location